Recent revelations indicate that 20% of the patients seeking medical attention at the Uganda Cancer Institute (UCI) are international visitors.
Established in 1967 to focus on lymphoma research and treatment, the UCI has evolved into a national and regional hub for cancer care excellence.
Dr. Nixon Niyonzima, a prominent figure at the institute, emphasized its burgeoning reputation, highlighting the significant influx of patients from neighbouring countries.
Despite the government’s considerable investment in healthcare, there remains a noticeable disparity in both infrastructure and human resources necessary for UCI to fully establish itself as a premier cancer treatment centre in the region.
Statistics from the institute suggest an annual incidence of over 34,000 new cancer cases in Uganda, with approximately 8,000 patients receiving treatment at the UCI annually.
Dr. Charles Ayume, Chairperson of the Parliament Health Committee, underscored the imperative for Uganda to position itself as the regional epicentre for cancer care excellence.
While cancer affects individuals across all age groups, children account for up to 40% of new cases reported to the UCI.
Despite a historical trend of Ugandans seeking cancer treatment abroad, there is a noticeable shift towards accessing quality healthcare domestically, particularly among the elite.
This transition signifies the enhancement of healthcare standards and accessibility at the UCI, further cementing its status as a preferred destination for cancer treatment, both locally and internationally.
